A. Sellas

647 total citations
19 papers, 300 citations indexed

About

A. Sellas is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, A. Sellas has authored 19 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 7 papers in Hematology and 7 papers in Immunology. Recurrent topics in A. Sellas's work include Rheumatoid Arthritis Research and Therapies (8 papers), Spondyloarthritis Studies and Treatments (7 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). A. Sellas is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Spondyloarthritis Studies and Treatments (7 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). A. Sellas collaborates with scholars based in Spain, Palestinian Territory and United States. A. Sellas's co-authors include Juan J. Gómez‐Reino, Eva Balada, Fernando Martínez‐Valle, Loreto Carmona, Segundo Buján-Rivas, Lydia Abásolo, Francisco J. de Abajo, Josep Ordi‐Ros, Beatriz Pérez-Zafrilla and M.Á. Descalzo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and British Journal of Dermatology.

In The Last Decade

A. Sellas

18 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Sellas Spain 10 193 138 56 41 41 19 300
B. Kroegler Italy 10 216 1.1× 179 1.3× 82 1.5× 39 1.0× 16 0.4× 24 383
Elisa Marocchi Italy 7 204 1.1× 143 1.0× 84 1.5× 38 0.9× 12 0.3× 8 337
Giuseppe Argentino Italy 9 100 0.5× 147 1.1× 70 1.3× 63 1.5× 30 0.7× 20 335
Mieke F. Pouw Netherlands 4 125 0.6× 143 1.0× 49 0.9× 23 0.6× 10 0.2× 6 285
V. Varisco Italy 5 103 0.5× 103 0.7× 34 0.6× 28 0.7× 11 0.3× 11 260
Izumi Kurata Japan 10 107 0.6× 119 0.9× 23 0.4× 41 1.0× 10 0.2× 19 268
Guo Xia China 10 254 1.3× 241 1.7× 101 1.8× 69 1.7× 9 0.2× 12 375
Sibel Balcı Türkiye 12 89 0.5× 124 0.9× 42 0.8× 141 3.4× 17 0.4× 47 326
Rabia Miray Kışla Ekinci Türkiye 12 91 0.5× 134 1.0× 49 0.9× 163 4.0× 17 0.4× 51 342
Andrea Skrabl‐Baumgartner Austria 8 91 0.5× 113 0.8× 89 1.6× 39 1.0× 54 1.3× 8 261

Countries citing papers authored by A. Sellas

Since Specialization
Citations

This map shows the geographic impact of A. Sellas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sellas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sellas more than expected).

Fields of papers citing papers by A. Sellas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sellas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sellas. The network helps show where A. Sellas may publish in the future.

Co-authorship network of co-authors of A. Sellas

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sellas. A scholar is included among the top collaborators of A. Sellas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sellas. A. Sellas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Monte‐Boquet, Emilio, et al.. (2023). Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain. Reumatología Clínica (English Edition). 19(8). 446–454.
2.
Galíndez-Agirregoikoa, E., D. Prieto-Peña, J. L. Martín-Varillas, et al.. (2021). Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice. The Journal of Rheumatology. 48(10). 1552–1558. 7 indexed citations
3.
Salgado, Eva, Montserrat Romera Baurés, E. Beltrán, et al.. (2021). Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review. Seminars in Arthritis and Rheumatism. 52. 151920–151920. 10 indexed citations
4.
García‐Vicuña, Rosario, Susana Gómez, Beatriz Joven, et al.. (2021). Management of particular clinical situations in psoriatic arthritis: an expert’s recommendation document based on systematic literature review and extended Delphi process. Rheumatology International. 41(9). 1549–1565. 8 indexed citations
5.
6.
Coras, Roxana, et al.. (2020). Analysis of the correlation between disease activity score 28 and its ultrasonographic equivalent in rheumatoid arthritis patients. SHILAP Revista de lepidopterología. 7(3). 118–123. 8 indexed citations
7.
López-Corbeto, Mireia, et al.. (2019). AB0334 THE OVARIAN RESERVE MEASURING THE ANTI-MüLLERIAN HORMONE IS NOT DIMINISHED IN PATIENTS WITH RHEUMATOID ARTHRITISCOMPARED TO THE HEALTHY POPULATION. Annals of the Rheumatic Diseases. 78. 1624–1624. 1 indexed citations
8.
Sánchez‐Piedra, Carlos, D. Ruiz-Montesinos, Carlos Rodríguez‐Lozano, et al.. (2018). Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER. Arthritis Research & Therapy. 20(1). 227–227. 4 indexed citations
9.
Almodóvar, Raquel, Juan Carlos Torre Alonso, Enrique Batlle, et al.. (2018). Development of a Checklist for Patients With Axial Spondyloarthritis and Psoriatic Arthritis in Daily Practice: ONLY TOOLS Project. Reumatología Clínica (English Edition). 14(3). 155–159. 5 indexed citations
10.
Almodóvar, Raquel, Juan Carlos Torre Alonso, Enrique Batlle, et al.. (2017). Desarrollo de un cuadro de actuación para la evaluación de pacientes con espondiloartritis axial y artritis psoriásica en la práctica diaria: proyecto ONLY TOOLS. Reumatología Clínica. 14(3). 155–159. 10 indexed citations
11.
Sellas, A., et al.. (2017). Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study). Rheumatology International. 37(11). 1817–1823. 16 indexed citations
12.
Adán, Alfredo, et al.. (2016). Burden and Direct Costs of Non Infectious Uveitis in Spain. Reumatología Clínica (English Edition). 12(4). 196–200. 14 indexed citations
13.
14.
Adán, Alfredo, et al.. (2015). Carga y costes directos de la uveítis no infecciosa en España. Reumatología Clínica. 12(4). 196–200. 23 indexed citations
15.
Carmona, Loreto, A. Sellas, Carlos Rodríguez‐Lozano, et al.. (2014). Scoring with the Berlin MRI method for assessment of spinal inflammatory activity in patients with ankylosing spondylitis: a calibration exercise among rheumatologists.. PubMed. 31(6). 883–8. 9 indexed citations
16.
Carmona, Loreto, Lydia Abásolo, M.Á. Descalzo, et al.. (2010). Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists. Seminars in Arthritis and Rheumatism. 41(1). 71–80. 81 indexed citations
17.
Martínez‐Valle, Fernando, Eva Balada, Josep Ordi‐Ros, et al.. (2009). DNase1 activity in systemic lupus erythematosus patients with and without nephropathy. Rheumatology International. 30(12). 1601–1604. 20 indexed citations
18.
Martínez‐Valle, Fernando, Eva Balada, Josep Ordi‐Ros, et al.. (2009). DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features. Lupus. 18(5). 418–423. 54 indexed citations
19.
Sellas, A., et al.. (1997). Amyloidosis in reactive arthritis.. PubMed. 15(5). 584–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Kroegler Breakdown of academic impact, for papers by Elisa Marocchi Breakdown of academic impact, for papers by Giuseppe Argentino Breakdown of academic impact, for papers by Mieke F. Pouw Breakdown of academic impact, for papers by V. Varisco Breakdown of academic impact, for papers by Izumi Kurata Breakdown of academic impact, for papers by Guo Xia Breakdown of academic impact, for papers by Sibel Balcı Breakdown of academic impact, for papers by Rabia Miray Kışla Ekinci Breakdown of academic impact, for papers by Andrea Skrabl‐Baumgartner
Rankless by CCL
2026